Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding the Combined Effects of High Glucose Induced Hyper-Osmotic Stress and Oxygen Tension in the Progression of Tumourigenesis: From Mechanism to Anti-Cancer Therapeutics. | Cells | 2023 | 36980166 | PubTator, text mining | PubMed |
| Knockdown SENP1 Suppressed the Angiogenic Potential of Mesenchymal Stem Cells by Impacting CXCR4-Regulated MRTF-A SUMOylation and CCN1 Expression. | Biomedicines | 2023 | 36979893 | PubTator, text mining | PubMed |
| Oxidative stress on vessels at the maternal-fetal interface for female reproductive system disorders: Update. | Front Endocrinol (Lausanne) | 2023 | 36967779 | PubTator, text mining | PubMed |
| UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS. | Elife | 2023 | 36951542 | PubTator, text mining | PubMed |
| The Ubiquitin-specific Protease USP36 Associates with the Microprocessor Complex and Regulates miRNA Biogenesis by SUMOylating DGCR8. | Cancer Res Commun | 2023 | 36950067 | PubTator, text mining | PubMed |
| SUMOylation mediates the disassembly of the Smad4 nuclear export complex via RanGAP1 in KELOIDS. | J Cell Mol Med | 2023 | 36916534 | PubTator, text mining | PubMed |
| Network and pathway-based analysis of candidate genes associated with esophageal adenocarcinoma. | J Gastrointest Oncol | 2023 | 36915458 | PubTator, text mining | PubMed |
| Residue selective crosslinking of proteins through photoactivatable or proximity-enabled reactivity. | Curr Opin Chem Biol | 2023 | 36913752 | PubTator, text mining | PubMed |
| The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing. | Nucleic Acids Res | 2023 | 36912080 | PubTator, text mining | PubMed |
| Regulation of SUMOylation on RNA metabolism in cancers. | Front Mol Biosci | 2023 | 36911524 | PubTator, text mining | PubMed |
| Transcriptomic profiling and differential analysis reveal the renal toxicity mechanisms of mice under cantharidin exposure. | Toxicol Appl Pharmacol | 2023 | 36907384 | PubTator, text mining | PubMed |
| The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | J Cell Biol | 2023 | 36880596 | PubTator, text mining | PubMed |
| Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment. | Cancer Res | 2023 | 36877156 | PubTator, text mining | PubMed |
| SMN post-translational modifications in spinal muscular atrophy. | Front Cell Neurosci | 2023 | 36874214 | PubTator, text mining | PubMed |
| An arrayed CRISPR screen of primary B cells reveals the essential elements of the antibody secretion pathway. | Front Immunol | 2023 | 36860866 | PubTator, text mining | PubMed |
| Loss of SENP3 mediated the formation of nasal polyps in nasal mucosal inflammation by increasing alternative activated macrophage. | Immun Inflamm Dis | 2023 | 36840491 | PubTator, text mining | PubMed |
| Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective. | Cells | 2023 | 36831310 | PubTator, text mining | PubMed |
| The Complex Genetic and Epigenetic Regulation of the Nrf2 Pathways: A Review. | Antioxidants (Basel) | 2023 | 36829925 | PubTator, text mining | PubMed |
| Post-ovulatory aging is associated with altered patterns for small ubiquitin-like modifier (SUMO) proteins and SUMO-specific proteases. | FASEB J | 2023 | 36826436 | PubTator, text mining | PubMed |
| X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma. | Curr Oncol | 2023 | 36826068 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=12